Cargando…
Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer
Cardiovascular disease is a significant cause of late morbidity and mortality in survivors of childhood cancer. Clinical informatics tools could enhance provider adherence to echocardiogram guidelines for early detection of late-onset cardiomyopathy. METHODS: Cancer registry data were linked to elec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848538/ https://www.ncbi.nlm.nih.gov/pubmed/34714665 http://dx.doi.org/10.1200/CCI.21.00099 |
_version_ | 1784871735426809856 |
---|---|
author | Noyd, David H. Berkman, Amy Howell, Claire Power, Steve Kreissman, Susan G. Landstrom, Andrew P. Khouri, Michel Oeffinger, Kevin C. Kibbe, Warren A. |
author_facet | Noyd, David H. Berkman, Amy Howell, Claire Power, Steve Kreissman, Susan G. Landstrom, Andrew P. Khouri, Michel Oeffinger, Kevin C. Kibbe, Warren A. |
author_sort | Noyd, David H. |
collection | PubMed |
description | Cardiovascular disease is a significant cause of late morbidity and mortality in survivors of childhood cancer. Clinical informatics tools could enhance provider adherence to echocardiogram guidelines for early detection of late-onset cardiomyopathy. METHODS: Cancer registry data were linked to electronic health record data. Structured query language facilitated the construction of anthracycline-exposed cohorts at a single institution. Primary outcomes included the data quality from automatic anthracycline extraction, sensitivity of International Classification of Disease coding for heart failure, and adherence to echocardiogram guideline recommendations. RESULTS: The final analytic cohort included 385 pediatric oncology patients diagnosed between July 1, 2013, and December 31, 2018, among whom 194 were classified as no anthracycline exposure, 143 had low anthracycline exposure (< 250 mg/m(2)), and 48 had high anthracycline exposure (≥ 250 mg/m(2)). Manual review of anthracycline exposure was highly concordant (95%) with the automatic extraction. Among the unexposed group, 15% had an anthracycline administered at an outside institution not captured by standard query language coding. Manual review of echocardiogram parameters and clinic notes yielded a sensitivity of 75%, specificity of 98%, and positive predictive value of 68% for International Classification of Disease coding of heart failure. For patients with anthracycline exposure, 78.5% (n = 62) were adherent to guideline recommendations for echocardiogram surveillance. There were significant association with provider adherence and race and ethnicity (P = .047), and 50% of patients with Spanish as their primary language were adherent compared with 90% of patients with English as their primary language (P = .003). CONCLUSION: Extraction of treatment exposures from the electronic health record through clinical informatics and integration with cancer registry data represents a feasible approach to assess cardiovascular disease outcomes and adherence to guideline recommendations for survivors. |
format | Online Article Text |
id | pubmed-9848538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-98485382023-01-19 Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer Noyd, David H. Berkman, Amy Howell, Claire Power, Steve Kreissman, Susan G. Landstrom, Andrew P. Khouri, Michel Oeffinger, Kevin C. Kibbe, Warren A. JCO Clin Cancer Inform Original Reports Cardiovascular disease is a significant cause of late morbidity and mortality in survivors of childhood cancer. Clinical informatics tools could enhance provider adherence to echocardiogram guidelines for early detection of late-onset cardiomyopathy. METHODS: Cancer registry data were linked to electronic health record data. Structured query language facilitated the construction of anthracycline-exposed cohorts at a single institution. Primary outcomes included the data quality from automatic anthracycline extraction, sensitivity of International Classification of Disease coding for heart failure, and adherence to echocardiogram guideline recommendations. RESULTS: The final analytic cohort included 385 pediatric oncology patients diagnosed between July 1, 2013, and December 31, 2018, among whom 194 were classified as no anthracycline exposure, 143 had low anthracycline exposure (< 250 mg/m(2)), and 48 had high anthracycline exposure (≥ 250 mg/m(2)). Manual review of anthracycline exposure was highly concordant (95%) with the automatic extraction. Among the unexposed group, 15% had an anthracycline administered at an outside institution not captured by standard query language coding. Manual review of echocardiogram parameters and clinic notes yielded a sensitivity of 75%, specificity of 98%, and positive predictive value of 68% for International Classification of Disease coding of heart failure. For patients with anthracycline exposure, 78.5% (n = 62) were adherent to guideline recommendations for echocardiogram surveillance. There were significant association with provider adherence and race and ethnicity (P = .047), and 50% of patients with Spanish as their primary language were adherent compared with 90% of patients with English as their primary language (P = .003). CONCLUSION: Extraction of treatment exposures from the electronic health record through clinical informatics and integration with cancer registry data represents a feasible approach to assess cardiovascular disease outcomes and adherence to guideline recommendations for survivors. Wolters Kluwer Health 2021-10-29 /pmc/articles/PMC9848538/ /pubmed/34714665 http://dx.doi.org/10.1200/CCI.21.00099 Text en © 2021 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Original Reports Noyd, David H. Berkman, Amy Howell, Claire Power, Steve Kreissman, Susan G. Landstrom, Andrew P. Khouri, Michel Oeffinger, Kevin C. Kibbe, Warren A. Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer |
title | Leveraging Clinical Informatics Tools to Extract Cumulative
Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline
Adherence for Children With Cancer |
title_full | Leveraging Clinical Informatics Tools to Extract Cumulative
Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline
Adherence for Children With Cancer |
title_fullStr | Leveraging Clinical Informatics Tools to Extract Cumulative
Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline
Adherence for Children With Cancer |
title_full_unstemmed | Leveraging Clinical Informatics Tools to Extract Cumulative
Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline
Adherence for Children With Cancer |
title_short | Leveraging Clinical Informatics Tools to Extract Cumulative
Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline
Adherence for Children With Cancer |
title_sort | leveraging clinical informatics tools to extract cumulative
anthracycline exposure, measure cardiovascular outcomes, and assess guideline
adherence for children with cancer |
topic | Original Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848538/ https://www.ncbi.nlm.nih.gov/pubmed/34714665 http://dx.doi.org/10.1200/CCI.21.00099 |
work_keys_str_mv | AT noyddavidh leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT berkmanamy leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT howellclaire leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT powersteve leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT kreissmansusang leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT landstromandrewp leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT khourimichel leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT oeffingerkevinc leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer AT kibbewarrena leveragingclinicalinformaticstoolstoextractcumulativeanthracyclineexposuremeasurecardiovascularoutcomesandassessguidelineadherenceforchildrenwithcancer |